Skip to main content
. 2019 Jun 15;29(2):020705. doi: 10.11613/BM.2019.020705

Table 2. Basic data of participants including the number of laboratories not monitoring haemolysis/icterus/lipemia.

Overall
(N = 1265)
Not monitoring HIL
(N = 105)
N (%)* N (%)**
Please state if you work in a:
Primary Care Laboratory 228 (18) 18 (7.9)
Hospital laboratory 496 (39) 53 (10.7)
Laboratory that serves both primary care and hospital (in- and outpatients) 541 (43) 34 (6.3)
Please state the type of institution you work in:
Privately owned (for-profit) laboratory 371 (29) 20 (5.4)
Public (non-profit) laboratory 894 (71) 85 (9.5)
What analytic department do you mainly work in?
General Clinical Chemistry 482 (38) 18 (3.7)
I work in many different analytic departments 322 (25) 11 (3.4)
Leading/Supervising position (e.g. head of department) 176 (14) 5 (2.8)
Haematology 65 (5.1) 11 (17)
Coagulation 12 (0.9) 1 (8.3)
Toxicology/TDM 5 (0.4) 2 (40)
Molecular biology 12 (0.9) 5 (42)
Microbiology 70 (5.5) 31 (44)
Reception/Distribution of samples 8 (0.6) 1 (12)
POCT 4 (0.3) 1 (25)
Quality Management 57 (4.5) 3 (5.3)
Transfusion 5 (0.4) 4 (80)
Clinical Pathology 1 (0.1) 1 (100)
Endocrinology 7 (0.6) 2 (29)
Serology/Virology 2 (0.2) 0 (0)
Other 12 (0.9) 4 (33)
Immunology 22 (1.7) 5 (23)
No answer 3 (0.2) 0 (0)
Samples per day
< 500 572 (45) 78 (14)
500–3000 484 (38) 26 (5.4)
3001–10,000 172 (14) 0 (0)
> 10,000 37 (2.9) 1 (2.7)
Is your laboratory accredited, certified or similar? (Multiple answers possible)
ISO 15189 582 (46) 48 (8.2)
ISO 17025 63 (5.0) 6 (9.5)
ISO 9001 239 (19) 18 (7.5)
ISO 22870 17 (1.3) 2 (12)
National standard 216 (17) 15 (6.9)
Ongoing accreditation/certification 26 (2.1) 6 (23)
Other 29 (2.3) 0 (0)
No accreditation/certification 245 (19) 21 (8.6)
TDM – therapeutic drug monitoring. POCT – point of care testing. Only answers from European countries stating to monitor preanalytical errors. *Percentage of total. **Percentage of the respective group.